Comparison of Preoxygenation Efficiency Measured by the Oxygen Reserve Index Between High-flow Nasal Oxygenation and Facemask Ventilation: a Randomised Controlled Trial
Overview
Affiliations
Background: High-flow nasal oxygenation and the oxygen reserve index (ORI), which is a non-invasive and innovative modality that reflects the arterial oxygen content, are used in general anaesthesia. This study compares the preoxygenation efficiency (measured by the ORI) of high-flow nasal oxygenation and facemask ventilation during the induction process.
Methods: This single-centre, two-group, randomised controlled trial included 197 patients aged ≥ 20 years who underwent orotracheal intubation for general anaesthesia for elective surgery. The patients were randomly allocated to receive preoxygenation via facemask ventilation or high-flow nasal oxygenation. The ORI was measured and compared between both groups.
Results: The ORI increased during preoxygenation in all patients. At 1 min of preoxygenation, the ORI was significantly higher in the high-flow nasal oxygenation group (0.34 ± 0.33) than in the facemask ventilation group (0.21 ± 0.28; P = 0.003). The highest ORI was not significantly different between the two groups (0.68 ± 0.25 in the high-flow nasal oxygenation group vs. 0.70 ± 0.28 in the facemask ventilation group; P = 0.505).
Conclusions: High-flow nasal oxygenation results in an oxygenation status similar to that provided by facemask ventilation during the induction process of general anaesthesia; therefore, high-flow nasal oxygenation is a feasible preoxygenation method.
Trial Registration: Clinicaltrials.gov (NCT04291339).
Mirzayev A, Cakmak G, Abdullayev R, Lacin T, Aykac Z, Saracoglu A North Clin Istanb. 2024; 11(5):382-390.
PMID: 39431038 PMC: 11487302. DOI: 10.14744/nci.2023.45556.
Zhong M, Xia R, Zhou J, Zhang J, Yi X, Yang A Front Med (Lausanne). 2024; 11:1379369.
PMID: 38912343 PMC: 11190303. DOI: 10.3389/fmed.2024.1379369.
Perioperative monitoring of the oxygen reserve: where do we stand?.
Massari D, de Keijzer I, Vos J J Clin Monit Comput. 2023; 37(6):1431-1433.
PMID: 37863861 DOI: 10.1007/s10877-023-01085-3.